Identification of Bladder Cancer Prognostic Biomarkers Using an Ageing Gene-related Competitive Endogenous RNA Network

Overview

Journal Oncotarget

Specialty Oncology

Date 2018 Jan 18

PMID 29340088

Citations 4

Authors

Changliang Wang

Liang Chen

Yang Yang

Menglei Zhang

Garry Wong

Affiliations

Soon will be listed here.

Abstract

Competitive endogenous RNAs (ceRNAs) are a newly proposed RNA interaction mechanism that has been associated with the initiation and progression of various cancers. In this study, we constructed an ageing gene related ceRNA network (AgeingCeNet) in bladder cancer. Network analysis revealed that ageing gene ceRNAs have a larger degree and closeness centrality than ageing genes themselves. Notably, the difference of betweenness centrality of ageing genes and their ceRNAs is not significant, suggesting that the ceRNAs of ageing genes and ageing genes themselves both play important communication roles in AgeingCeNet. KEGG pathway enrichment analysis for genes in AgeingCeNet revealed that AgeingCeNet genes are enriched in cancer pathways and several cancer related singaling pathways. We also identified 37 core modules from AgeingCeNet using CFinder software. Next, we identified 2 potential prognostic modules, named K11M14 and K13M4, whose prognostic ability is better than that of age and gender. Finally, we identified microRNAs (miRNAs) regulating the two modules, which include miR-15b-5p, miR-195-5p, miR-30 family members, and several other cancer-related miRNAs. Our study demonstrated that constructing an ageing gene related ceRNA network is a feasible strategy to explore the mechanism of initiation and progression of bladder cancer, which might benefit the treatment of this disease.

Citing Articles

LncRNA LINC00466 Promotes the Progression of Breast Cancer miR-4731-5p/EPHA2 Pathway.

Han X, Shi F, Guo S, Li Y, Wang H, Song C Curr Pharm Biotechnol. 2024; 26(1):120-131.

PMID: 38726776 DOI: 10.2174/0113892010290582240419051056.

Data analysis methods for defining biomarkers from omics data.

Li C, Gao Z, Su B, Xu G, Lin X Anal Bioanal Chem. 2021; 414(1):235-250.

PMID: 34951658 DOI: 10.1007/s00216-021-03813-7.

Identification of the Key Factors Related to Bladder Cancer by lncRNA-miRNA-mRNA Three-Layer Network.

Wang X, Ding Y, Wang J, Wu Y Front Genet. 2020; 10:1398.

PMID: 32047516 PMC: 6997565. DOI: 10.3389/fgene.2019.01398.

Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer.

Wang J, Huang Y, Song W, Li Y, Wang H, Wang W Oncol Rep. 2019; 42(6):2572-2582.

PMID: 31638237 PMC: 6826329. DOI: 10.3892/or.2019.7374.

References

Xu J, Li Y, Lu J, Pan T, Ding N, Wang Z . The mRNA related ceRNA-ceRNA landscape and significance across 20 major cancer types. Nucleic Acids Res. 2015; 43(17):8169-82. PMC: 4787795. DOI: 10.1093/nar/gkv853. View

Li J, Liu S, Zhou H, Qu L, Yang J . starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2013; 42(Database issue):D92-7. PMC: 3964941. DOI: 10.1093/nar/gkt1248. View

Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999; 28(1):27-30. PMC: 102409. DOI: 10.1093/nar/28.1.27. View

Zhao F, Lin T, He W, Han J, Zhu D, Hu K . Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer. Oncotarget. 2014; 6(2):1064-78. PMC: 4359217. DOI: 10.18632/oncotarget.2833. View

Knowles M, Hurst C . Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer. 2014; 15(1):25-41. DOI: 10.1038/nrc3817. View

Merico D, Isserlin R, Stueker O, Emili A, Bader G . Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One. 2010; 5(11):e13984. PMC: 2981572. DOI: 10.1371/journal.pone.0013984. View

Li J, Han L, Roebuck P, Diao L, Liu L, Yuan Y . TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer. Cancer Res. 2015; 75(18):3728-37. PMC: 4573884. DOI: 10.1158/0008-5472.CAN-15-0273. View

Wang P, Guo Q, Gao Y, Zhi H, Zhang Y, Liu Y . Improved method for prioritization of disease associated lncRNAs based on ceRNA theory and functional genomics data. Oncotarget. 2016; 8(3):4642-4655. PMC: 5354861. DOI: 10.18632/oncotarget.13964. View

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

10.

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

11.

Harris S, Levine A . The p53 pathway: positive and negative feedback loops. Oncogene. 2005; 24(17):2899-908. DOI: 10.1038/sj.onc.1208615. View

12.

Tomczak K, Czerwinska P, Wiznerowicz M . The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015; 19(1A):A68-77. PMC: 4322527. DOI: 10.5114/wo.2014.47136. View

13.

White M, Holman D, Boehm J, Peipins L, Grossman M, Henley S . Age and cancer risk: a potentially modifiable relationship. Am J Prev Med. 2014; 46(3 Suppl 1):S7-15. PMC: 4544764. DOI: 10.1016/j.amepre.2013.10.029. View

14.

Recio-Boiles A, Ilmer M, Rhea P, Kettlun C, Heinemann M, Ruetering J . JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells. Oncotarget. 2016; 7(9):9890-906. PMC: 4891091. DOI: 10.18632/oncotarget.7066. View

15.

Shariat S, Sfakianos J, Droller M, Karakiewicz P, Meryn S, Bochner B . The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int. 2009; 105(3):300-8. PMC: 4315315. DOI: 10.1111/j.1464-410X.2009.09076.x. View

16.

Huang D, Sherman B, Lempicki R . Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2008; 37(1):1-13. PMC: 2615629. DOI: 10.1093/nar/gkn923. View

17.

Cavanagh H, Rogers K . The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers. Hered Cancer Clin Pract. 2015; 13(1):16. PMC: 4521499. DOI: 10.1186/s13053-015-0038-x. View

18.

Adamcsek B, Palla G, Farkas I, Derenyi I, Vicsek T . CFinder: locating cliques and overlapping modules in biological networks. Bioinformatics. 2006; 22(8):1021-3. DOI: 10.1093/bioinformatics/btl039. View

19.

Chou C, Chang N, Shrestha S, Hsu S, Lin Y, Lee W . miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res. 2015; 44(D1):D239-47. PMC: 4702890. DOI: 10.1093/nar/gkv1258. View

20.

Dhillon A, Hagan S, Rath O, Kolch W . MAP kinase signalling pathways in cancer. Oncogene. 2007; 26(22):3279-90. DOI: 10.1038/sj.onc.1210421. View